NY Department of Health Approves Personalis' ACE Exome Testing

Apr 24, 2017

|

NEW YORK (GenomeWeb) – Diagnostic sequencing firm Personalis announced it has received approval from the New York State Department of Health for two clinical tests based on its ACE Exome for Inherited Disorders offering.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

NY Department of Health Approves Personalis' ACE Exome Testing

To read the full story....

Breaking News

PerkinElmer Preliminary Q1 Revenues Grow 98 Percent; FDA Issues EUA for PCR COVID-19 Test

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

Ethos Labs, Agena Biosciences Partner on SARS-CoV-2 Variant Identification

Danaher Expects Q1 2021 Revenue Growth Above Previous Guidance

Australian Firm AnteoTech Obtains CE Marking for COVID-19 Antigen Test, Reader

Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit

Featured White Papers

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

What's Popular?

FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines

Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx

Sponsorships